30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Trius Therapeutics LLC (TSRX)

Stock chart
Ticker: TSRX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Finn John
Chief Scientific Officer
1 sale — total 50,500 USD
Planned sale 12 Jul 2013
Value US$1,693,695.35 | Price 253.18 | Shares 16,088
Planned sale 11 Jul 2013
Value US$1,394,614.19 | Price 130.49 | Shares 70,557
Planned sale 11 Jul 2013
Value US$4,660.00 | Price 9.32 | Shares 500
Planned sale 14 May 2013
Value US$155,000.00 | Price 7.75 | Shares 20,000
Planned sale 19 Jan 2012
Value US$14,661.92 | Price 5.64 | Shares 2,600
Planned sale 17 Jan 2012
Value US$87,426.22 | Price 5.43 | Shares 16,100
Buy 29 Aug 2011
Value US$13,600.00 | Price 6.80 | Shares 2,000
Buy 22 Aug 2011
Value US$861.84 | Price 6.48 | Shares 133
Planned sale 12 Aug 2011
Value US$2,100.00 | Price 7.00 | Shares 300
Planned sale 9 Aug 2011
Value US$4,800.00 | Price 6.00 | Shares 800
Planned sale 1 Aug 2011
Value US$3,600.00 | Price 9.00 | Shares 400
Planned sale 1 Jun 2011
Value US$800.00 | Price 8.00 | Shares 100
Planned sale 3 May 2011
Value US$1,200.00 | Price 6.00 | Shares 200
Planned sale 18 Feb 2011
Value US$3,000.00 | Price 6.00 | Shares 500
Buy 23 Nov 2010
Value US$3,500.00 | Price 3.50 | Shares 1,000
Buy 6 Aug 2010
Value US$4,150,000.00 | Price 5.00 | Shares 830,000
Buy 6 Aug 2010
Value US$24,505.00 | Price 5.00 | Shares 4,901
Buy 6 Aug 2010
Value US$4,119,530.00 | Price 5.00 | Shares 823,906
Buy 6 Aug 2010
Value US$4,572,645.00 | Price 5.00 | Shares 914,529
Buy 6 Aug 2010
Value US$24,505.00 | Price 5.00 | Shares 4,901
Buy 6 Aug 2010
Value US$4,572,645.00 | Price 5.00 | Shares 914,529
Buy 6 Aug 2010
Value US$6,136,665.00 | Price 5.00 | Shares 1,227,333
Buy 6 Aug 2010
Value US$6,136,665.00 | Price 5.00 | Shares 1,227,333
Buy 6 Aug 2010
Value US$5,970,175.00 | Price 5.00 | Shares 1,194,035
Buy 6 Aug 2010
Value US$4,150,000.00 | Price 5.00 | Shares 830,000
Buy 6 Aug 2010
Value US$6,136,665.00 | Price 5.00 | Shares 1,227,333
Buy 6 Aug 2010
Value US$150,000.00 | Price 5.00 | Shares 30,000
Buy 6 Aug 2010
Value US$4,119,530.00 | Price 5.00 | Shares 823,906
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2013-07-12 2013-07-12 PlS Planned sale Finn John

Chief Scientific Officer

Officer
16,088 +8.9%
253.18
US$1,693,695
16,088 +8.9% 253.18 US$1,693,695
2013-07-12 2013-07-11 PlS Planned sale MORNEAU MICHAEL

VP Finance & CAO

Officer
70,557 +21.5%
130.49
US$1,394,614
70,557 +21.5% 130.49 US$1,394,614
2013-07-12 2013-07-11 PlS Planned sale Finn John

Chief Scientific Officer

Officer
50,878 +37.5%
130.48
US$3,233,356
50,878 +37.5% 130.48 US$3,233,356
2013-05-16 2013-05-14 PlS Planned sale MORNEAU MICHAEL

VP Finance & CAO

Officer
20,000 -65.3%
7.75
US$155,000
20,000 -65.3% 7.75 US$155,000
2012-01-20 2012-01-19 PlS Planned sale POWELL MICHAEL Non-Executive Director
2,600 -2.2%
5.64
US$14,662
2,600 -2.2% 5.64 US$14,662
2012-01-17 2012-01-17 PlS Planned sale POWELL MICHAEL Non-Executive Director
16,100 -11.8%
5.43
US$87,426
16,100 -11.8% 5.43 US$87,426
2011-08-31 2011-08-29 B Purchase TRUEX PAUL F Non-Executive Director
2,000 +17.7%
6.80
US$13,600
2,000 +17.7% 6.80 US$13,600
2011-08-24 2011-08-22 B Purchase THOMPSON JOHN CRAIG

Chief Commercial Officer

Officer
133 +inf%
6.48
US$862
133 +inf% 6.48 US$862
2011-08-12 2011-08-12 PlS Planned sale Finn John

Chief Scientific Officer

Officer
300 -0.2%
7.00
US$2,100
300 -0.2% 7.00 US$2,100
2011-08-10 2011-08-09 PlS Planned sale Finn John

Chief Scientific Officer

Officer
800 -0.5%
6.00
US$4,800
800 -0.5% 6.00 US$4,800
2011-08-02 2011-08-01 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
400 -0.4%
9.00
US$3,600
400 -0.4% 9.00 US$3,600
2011-06-01 2011-06-01 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
100 -0.1%
8.00
US$800
100 -0.1% 8.00 US$800
2011-05-03 2011-05-03 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
200 -0.2%
6.00
US$1,200
200 -0.2% 6.00 US$1,200
2011-02-22 2011-02-18 PlS Planned sale Finn John

Chief Scientific Officer

Officer
500 -0.3%
6.00
US$3,000
500 -0.3% 6.00 US$3,000
2010-11-24 2010-11-23 B Purchase TRUEX PAUL F Non-Executive Director
1,000 +9.7%
3.50
US$3,500
1,000 +9.7% 3.50 US$3,500
2010-08-10 2010-08-06 B Purchase POWELL MICHAEL Non-Executive Director Large shareholder
830,000 +29.8%
5.00
US$4,150,000
830,000 +29.8% 5.00 US$4,150,000
2010-08-10 2010-08-06 B Purchase KPCB PBD Associates, LLC Large shareholder
4,901 +0.2%
5.00
US$24,505
4,901 +0.2% 5.00 US$24,505
2010-08-10 2010-08-06 B Purchase KPCB PBD Associates, LLC Large shareholder
823,906 +52.7%
5.00
US$4,119,530
823,906 +52.7% 5.00 US$4,119,530
2010-08-10 2010-08-06 B Purchase Versant Venture Capital III, L.P. Large shareholder
914,529 +39.4%
5.00
US$4,572,645
914,529 +39.4% 5.00 US$4,572,645
2010-08-10 2010-08-06 B Purchase KPCB PBD Founders Fund, LLC Large shareholder
4,901 +53.0%
5.00
US$24,505
4,901 +53.0% 5.00 US$24,505
2010-08-10 2010-08-06 B Purchase ATWOOD BRIAN G Non-Executive Director Large shareholder
914,529 +39.4%
5.00
US$4,572,645
914,529 +39.4% 5.00 US$4,572,645
2010-08-10 2010-08-06 B Purchase InterWest Partners IX, LP

General Partner

Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665
1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase InterWest Partners IX, LP

Venture Member

Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665
1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase Prism Venture Partners V L P Large shareholder
1,194,035 +67.7%
5.00
US$5,970,175
1,194,035 +67.7% 5.00 US$5,970,175
2010-08-10 2010-08-06 B Purchase SOFINNOVA VENTURE PARTNERS VII L P Large shareholder
830,000 +29.8%
5.00
US$4,150,000
830,000 +29.8% 5.00 US$4,150,000
2010-08-10 2010-08-06 B Purchase Kjellson Nina S Non-Executive Director Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665
1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase KABAKOFF DAVID S Non-Executive Director
30,000 +656.5%
5.00
US$150,000
30,000 +656.5% 5.00 US$150,000
2010-08-10 2010-08-06 B Purchase KPCB PANDEMIC & BIO DEFENSE FUND LLC Large shareholder
823,906 +53.0%
5.00
US$4,119,530
823,906 +53.0% 5.00 US$4,119,530
Explore more

More insider trading research around Trius Therapeutics LLC